1
|
Thévenot T. Letter: using a placebo as a comparator to rifaximin for the primary prophylaxis of spontaneous bacterial peritonitis-is there really an ethical concern? Aliment Pharmacol Ther 2018. [PMID: 29512907 DOI: 10.1111/apt.14544] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- T Thévenot
- Service d'Hépatologie et de Soins Intensifs Digestifs, Hôpital Jean Minjoz, Besançon Cedex, France
| | | |
Collapse
|
2
|
Goel A, Nguyen MH. Editorial: rifaximin-a kick in the gut for spontaneous bacterial peritonitis? Authors' reply. Aliment Pharmacol Ther 2018; 47:303. [PMID: 29265465 DOI: 10.1111/apt.14450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- A Goel
- Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA
| | - M H Nguyen
- Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA
| |
Collapse
|